Displaying 231–240 of 303 research results
May 4, 2016
In August 2015, the biotech company Alkeus launched a multi-center TEASE Phase II clinical trial for the drug ALK-001.
May 3, 2016
There are innumerable considerations for researchers developing therapies.
May 2, 2016
When the study and the reports are completed, the ProgSTAR database will be made available to researchers and companies developing therapies.
Apr 28, 2016
Five of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.
Mar 17, 2016
Dr. Shannon Boye and her Foundation-funded research is the subject of not just one but two new Foundation videos.
Dec 22, 2015
If you have a heritable retinal disease, consider registering with My Retina Tracker, the Foundation’s free, secure and confidential registry for people with inherited retinal diseases.
Nov 11, 2015
Researchers from the University of Cologne in Germany and Radboud University in the Netherlands found that increased sunlight exposure during working life significantly increases risk of AMD later in life.
Oct 8, 2015
Aug 4, 2015
40 percent of genetically tested XLRP carriers showed a definitive abnormality in at least one of three visions tests.
Jul 28, 2015
A pioneering, 80-year-old named Ray Flynn is the first AMD patient to receive the Argus II, and he is already reporting that he can see things better in his garden.